US Broker Ratings

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 101% Upside Potential with Strong Buy Ratings

ADMA Biologics Inc (NASDAQ: ADMA), a key player in the biotechnology industry, is capturing investor attention with its impressive potential upside of 101.14%. Operating within the healthcare sector, ADMA focuses..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a Tightrope with Potential and Caution

Bio-Techne Corp (NASDAQ: TECH) is a significant player in the biotechnology sector, operating at the crossroads of healthcare and technology. With a market capitalization of $11.06 billion, this Minneapolis-based company..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring Growth Potential Amidst Notable Revenue Surge

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, has been capturing investor interest with its impressive market performance and innovative therapeutic solutions. With a market capitalization..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth with a $10.39 Billion Market Cap

Charles River Laboratories International, Inc. (NYSE: CRL), a key player in the healthcare sector specializing in diagnostics and research, is drawing attention with its impressive market cap of $10.39 billion...

Alkermes plc (ALKS) Stock Analysis: Navigating Growth Amidst a Potential -12.63% Downside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, has been attracting significant attention from investors with its robust lineup of pharmaceutical products targeting unmet medical needs. Despite..

Natera, Inc. (NTRA) Stock Analysis: A Leading Diagnostic Innovator with Robust Revenue Growth and Strong Buy Ratings

Investors with a keen eye on the healthcare sector may find Natera, Inc. (NASDAQ: NTRA) an intriguing opportunity. As a prominent player in the diagnostics and research industry, Natera is..

Zoetis Inc. (ZTS) Stock Analysis: Is a 62.96% Upside Worth the Investment?

For investors eyeing the healthcare sector, Zoetis Inc. (ZTS) presents a compelling opportunity with a significant potential upside of 62.96%, according to analyst ratings. With a market cap of $31.9..

West Pharmaceutical Services (WST) Stock Analysis: Strong Revenue Growth and Bullish Analyst Ratings Offer Promising Prospects

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector with a focus on medical instruments and supplies, has been capturing investor attention with its robust market..

Centene Corporation (CNC) Stock Analysis: Navigating the Healthcare Sector with a -5.93% Potential Downside

Centene Corporation (NYSE: CNC), a significant player in the healthcare plans industry, presents an intriguing case for investors navigating the dynamic healthcare sector. With a market capitalization of $32.46 billion,..

Guardant Health, Inc. (GH) Stock Analysis: Navigating High Growth in the Diagnostics Sector

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, is making waves in the healthcare sector with its cutting-edge diagnostic technologies. Headquartered in Palo Alto, California, this company is..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Strong Buy Ratings Amid Impressive ROE and Expanding Diagnostic Portfolio

Lantheus Holdings, Inc. (NASDAQ: LNTH) presents an intriguing proposition for investors focused on the healthcare sector, particularly in the specialty and generic drug manufacturing industry. With a market capitalization of..

Stevanato Group S.p.A. (STVN) Stock Analysis: Uncovering a 37% Upside Potential in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), an Italian stalwart in the healthcare sector, has captured investors’ attention with its promising growth potential, reflected in a striking 37.05% upside based on analysts’..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and Revenue Growth Propel Healthcare Giant Forward

Cardinal Health, Inc. (NYSE: CAH), a titan in the healthcare sector, operates primarily in the medical distribution industry. With a market capitalization of $55.72 billion, the company has established itself..

Insulet Corporation (PODD) Stock Analysis: Impressive Growth Potential with a 51.82% Upside

Insulet Corporation (NASDAQ: PODD), a leader in the healthcare sector specializing in medical devices, is making waves with its innovative insulin delivery systems. With a market capitalization of $10.96 billion,..

Novo Nordisk A/S (NVO) Stock Analysis: Navigating a Healthcare Giant with a 71.4% ROE

Novo Nordisk A/S (NVO), a prominent player in the healthcare sector, has long been a beacon of innovation in the pharmaceutical industry. With its extensive reach across global markets, the..

Glaukos Corporation (GKOS) Stock Analysis: High Growth and Strong Buy Ratings Drive Investor Interest

Glaukos Corporation (GKOS), a key player in the medical devices industry, is gaining significant attention from investors, thanks to its robust growth metrics and strong endorsement from analysts. Specializing in..

Waters Corporation (WAT) Stock Analysis: Navigating a 91.4% Revenue Surge with Analyst Optimism

Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector’s Diagnostics & Research industry, is capturing investor attention with its robust growth trajectory and favorable analyst sentiment. Headquartered in..

Penumbra, Inc. (PEN) Stock Analysis: A 15% Upside Potential in the Medical Devices Sector

Penumbra, Inc. (NYSE: PEN) stands out as a dynamic player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $12.45 billion, the company has..

Grifols, S.A. (GRFS) Stock Analysis: Potential Upside of 47% Sparks Investor Interest

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector and a key contributor to the drug manufacturing industry, is captivating the attention of investors with its promising potential..

Moderna, Inc. (MRNA) Stock Analysis: Evaluating the 260% Revenue Growth Amidst a Volatile Market

Moderna, Inc. (NASDAQ: MRNA) has become a household name in the biotechnology industry, especially following its pivotal role in developing the COVID-19 vaccine. As of the latest financial data, Moderna’s..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds